Immuron (IMRN) Enterprise Value (2016 - 2025)
Immuron (IMRN) recorded quarterly Enterprise Value of -$28305.3 in Q3 2025, up 98.44% quarter-over-quarter from -$1.8 million in Q2 2025, and up 99.76% on a YoY basis from -$14169.8 in Q3 2024.
Immuron (IMRN) Enterprise Value (2016 - 2025) Analysis & Trends
Immuron's Enterprise Value history runs 10 years deep, the most recent figure standing at -$28305.3 for Q3 2025.
- In Q3 2025, Enterprise Value rose 99.76% year-over-year to -$28305.3; the TTM figure through Sep 2025 stood at -$28305.3 (up 99.76% YoY), while the FY2025 annual figure was -$28305.3, up 99.76% from the prior year.
- Enterprise Value was -$28305.3 for Q3 2025 at Immuron, up from -$1.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$28305.3 in Q3 2025 to a low of -$19.3 million in Q2 2021.
- Historically, Enterprise Value has averaged -$10.8 million across 5 years, with a median of -$12.2 million in 2024.
- The sharpest annual moves came in 2021 and 2025: Enterprise Value tumbled 805.35% in 2021, then jumped 99.76% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$2.4 million in 2021, then tumbled by 591.63% to -$16.5 million in 2022, then soared by 32.12% to -$11.2 million in 2023, then surged by 54.71% to -$5.1 million in 2024, then soared by 99.44% to -$28305.3 in 2025.
- The last three Enterprise Value figures came in at -$28305.3 (Q3 2025), -$1.8 million (Q2 2025), and -$5.1 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -584.73 Mn |
| 10 | Immuron | 1.05 Bn | 1.05 Bn | - | -28,305.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | -28,305.26 |
| Jun 30, 2025 | -1.81 Mn |
| Dec 31, 2024 | -5.06 Mn |
| Sep 9, 2024 | -11.66 Mn |
| Jun 30, 2024 | -7.68 Mn |
| Dec 31, 2023 | -11.17 Mn |
| Sep 28, 2023 | -14.49 Mn |
| Aug 30, 2023 | -17.16 Mn |
| Jun 30, 2023 | -12.69 Mn |
| Dec 31, 2022 | -16.46 Mn |
| Aug 31, 2022 | -15.38 Mn |
| Jun 30, 2022 | -15.84 Mn |
| Dec 31, 2021 | -2.38 Mn |
| Jun 30, 2021 | -19.29 Mn |
| Dec 31, 2020 | -3.74 Mn |
| Sep 1, 2020 | -3.25 Mn |
| Jun 30, 2020 | -2.13 Mn |
| Dec 31, 2019 | -32,504.68 |
| Jun 30, 2019 | -3.59 Mn |
| Dec 31, 2018 | -4.73 Mn |